ArticleFrontiers in immunology2023

Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China.

Yuting Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.